Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.

about

Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins.Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer

P2860

Q55119439-6CBF3D92-7A1C-4AB0-B0AB-61283DE493F2 Q58608661-0F79D12B-5D39-4BC0-9702-135B1E41D14E

P2860

Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.

Item

http://www.wikidata.org/entity/Q38722475

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Multiagent induction chemother ...... ly advanced pancreatic cancer.

@en

type

Item

label

Multiagent induction chemother ...... ly advanced pancreatic cancer.

@en

prefLabel

Multiagent induction chemother ...... ly advanced pancreatic cancer.

@en

P1476

Multiagent induction chemother ...... ly advanced pancreatic cancer.

@en

P2093

Anna Torgeson

http://www.w3.org/2001/XMLSchema#string

Dustin Boothe

http://www.w3.org/2001/XMLSchema#string

George M Cannon

http://www.w3.org/2001/XMLSchema#string

Jonathan Whisenant

http://www.w3.org/2001/XMLSchema#string

Randa Tao

http://www.w3.org/2001/XMLSchema#string

Shane Lloyd

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.

Cancer statistics, 2016

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

The National Cancer Data Base: a powerful initiative to improve cancer care in the United States

A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.

Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration

P31

scholarly article

P356

10.1002/CNCR.30780

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Ignacio Garrido-Laguna

P577

2017-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28621885

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.

about

P2860

P2860

Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P921